AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+16.3%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$5.04B
AUM Growth
+$5.04B
Cap. Flow
-$114M
Cap. Flow %
-2.26%
Top 10 Hldgs %
92.8%
Holding
109
New
12
Increased
18
Reduced
24
Closed
12

Top Buys

1
CLVS
Clovis Oncology, Inc.
CLVS
$7.42M
2
ARRY
Array Biopharma Inc
ARRY
$6.77M
3
GBT
Global Blood Therapeutics, Inc.
GBT
$6.21M
4
BOLD
Audentes Therapeutics, Inc
BOLD
$5.6M
5
PRQR icon
ProQR Therapeutics
PRQR
$4.85M

Top Sells

1
GS icon
Goldman Sachs
GS
$22.2M
2
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$18.1M
3
AGIO icon
Agios Pharmaceuticals
AGIO
$16.7M
4
BLUE
bluebird bio
BLUE
$15.8M
5
ALXN
Alexion Pharmaceuticals Inc
ALXN
$12.2M

Sector Composition

1 Consumer Staples 49.27%
2 Consumer Discretionary 25.43%
3 Healthcare 24.54%
4 Financials 0%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DVAX icon
51
Dynavax Technologies
DVAX
$1.18B
$3.23M 0.06%
+150,000
New +$3.23M
JNCE
52
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$3.12M 0.05%
200,000
-50,000
-20% -$779K
CLLS
53
Cellectis
CLLS
$264M
$2.85M 0.05%
100,000
– –
CBIO
54
Crescent Biopharma, Inc. Common Stock
CBIO
$184M
$2.83M 0.05%
202,500
– –
STML
55
DELISTED
Stemline Therapeutics, Inc.
STML
$2.78M 0.05%
250,000
– –
CALA
56
DELISTED
Calithera Biosciences, Inc
CALA
$2.76M 0.05%
175,000
-25,000
-13% -$394K
FGEN icon
57
FibroGen
FGEN
$47.6M
$2.69M 0.05%
+50,000
New +$2.69M
RARE icon
58
Ultragenyx Pharmaceutical
RARE
$3.06B
$2.66M 0.05%
50,000
– –
CMRX
59
DELISTED
Chimerix, Inc.
CMRX
$2.63M 0.05%
500,000
– –
XNCR icon
60
Xencor
XNCR
$586M
$2.29M 0.04%
+100,000
New +$2.29M
KDNY
61
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.13M 0.04%
200,000
+100,000
+100% +$1.07M
FPRX
62
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.05M 0.04%
50,000
-100,000
-67% -$4.09M
CLDX icon
63
Celldex Therapeutics
CLDX
$1.56B
$1.93M 0.03%
675,000
– –
NERV icon
64
Minerva Neurosciences
NERV
$15.9M
$1.91M 0.03%
251,300
– –
BHVN
65
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.87M 0.03%
+50,000
New +$1.87M
NVLN
66
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$1.8M 0.03%
256,400
– –
SNDX icon
67
Syndax Pharmaceuticals
SNDX
$1.37B
$1.79M 0.03%
152,920
-147,080
-49% -$1.72M
LUMO
68
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.53M 0.03%
+150,000
New +$1.53M
KURA icon
69
Kura Oncology
KURA
$719M
$1.5M 0.03%
+100,000
New +$1.5M
DMTX
70
DELISTED
Dimension Therapeutics, Inc
DMTX
$1.41M 0.02%
234,493
– –
ATYR
71
aTyr Pharma
ATYR
$558M
$1.26M 0.02%
+250,000
New +$1.26M
IBRX icon
72
ImmunityBio
IBRX
$2.24B
$1.23M 0.02%
225,000
– –
ARGX icon
73
argenx
ARGX
$43.4B
$1.23M 0.02%
+54,337
New +$1.23M
IMDX
74
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$73.8M
$1.13M 0.02%
150,000
– –
CRBP icon
75
Corbus Pharmaceuticals
CRBP
$119M
$1.07M 0.02%
150,000
-100,000
-40% -$715K
1 2
3
4 5